Safety and Immunogenicity of CHIKV VLP Vaccine PXVX0317 in Adults ≥65 Years

Clinical trial NCT05349617 · COMPLETED

Trial details

NCT number: NCT05349617
Sponsor: Bavarian Nordic
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chikungunya Virus

Start date: 2022-05-12
Primary completion: 2023-06-19
Enrollment: 413

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.